Compare ArcelorMittal SA (MT) vs Recursion Pharmaceuticals Inc (RXRX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
ArcelorMittal SA vs Recursion Pharmaceuticals Inc — how do they compare? ArcelorMittal SA trades at $66.25 (market cap $50.01B), while Recursion Pharmaceuticals Inc trades at $3.08 (market cap $1.53B). The key difference: ArcelorMittal SA is far larger — about 32.7× Recursion Pharmaceuticals Inc's market cap, and ArcelorMittal SA pays a 0.91% dividend while Recursion Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| MT | RXRX | |
|---|---|---|
Market Cap | $50.01B | $1.53B |
Sector | Basic Materials | Health |
52-Week High | $71.65 | $6.79 |
52-Week Low | $30.39 | $2.84 |
Enterprise Value | $59.33B | $946.50M |
Dividend Yield | 0.91% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ArcelorMittal SA
ArcelorMittal SA is involved in the steel industry. The company's operating segments include NAFTA
Read more on MT →About Recursion Pharmaceuticals Inc
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company leveraging artificial intelligence (AI) and machine learning to industrialize drug discovery. The company's unique approach combines one of the world's largest biological and chemical datasets with automated wet-lab and computational systems to map human biology and identify potential therapeutic candidates across a range of diseases, including oncology and rare diseases. Recursion aims to accelerate the traditionally slow and expensive process of drug development.
Read more on RXRX →
